Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic
  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

RYAH Group, Inc. To Present at LD Micro Conference on October 12th

TORONTO, ON / ACCESSWIRE / October 5, 2021 / RYAH Group, Inc. (CSE:RYAH) ("RYAH" or the "Company") is pleased to announce that Gregory Wagner, the Chief Executive Officer of the Company, will be presenting at the virtual LD Micro conference on Tuesday, October 12th.

The upcoming interactive online event is expected to give Mr. Wagner an opportunity to highlight RYAH's mission and approach for the audience of investment community professionals and existing shareholders.

The Company is scheduled to present at 10:30 a.m. (Eastern time). Mr. Wagner is expected to elaborate on the Company's recent developments and plans, and potentially open the floor for questions. Participants will be able to send their questions during the livestream conference.

Please register here to ensure you are able to attend the livestream conference and receive any updates that are released.

If attendees are not able to join the event live on the day of the conference, an archived webcast will be made available after the event.

About RYAH Group, Inc.
RYAH is a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry. Its robust artificial intelligence platform aggregates and correlates Health Insurance Portability and Accountability Act (HIPAA)-compliant patient data, which is intended to help doctors and patients personalize plant-based treatments to better predict treatment outcomes. The data collection is relevant for clinics, doctors, dispensaries and pharmaceutical companies and licensed processors (LPs) to monitor and manage formulation effects on patient and demographics. With a strong intellectual property portfolio, RYAH gathers deep and insightful data on the complete patient session and formulation lifecycle.

Forward-Looking Statements
This press release contains certain forward-looking information and forward-looking statements within the meaning of applicable securities legislation (collectively "forward-looking statements"). All statements contained in this press release that are not statements of historical fact should be considered forward-looking statements. Forward looking statements are often identified by terms such as "may", "should", "anticipate", "expect", "potential", "believe", "intend" or the negative of these terms and similar expressions. Specifically, forward-looking statements in this press release include but are not limited to, statements related to the "Next Super Stock" livestream conference, including the timing thereof and the scope and content(s) of Mr. Wagner's presentation. Forward-looking statements reflect the Company's current views and intentions with respect to future events based on current information available to the Company, and are necessarily subject to certain risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with or inherent in the general business, technological, and economic conditions which may affect the scheduled "Next Super Stock" livestream conference, and such other applicable factors set out in the Company's public disclosure documents available under the Company's profile on SEDAR at www.sedar.com. Readers are further cautioned that the assumptions used in the preparation of such forward-looking statements (including, but not limited to, the assumption that Mr. Wagner will be able to virtually attend and present at the "Next Super Stock" livestream conference as contemplated herein, and that there will not be any factor (whether technological or otherwise) that may delay or impede the conduct of the said livestream conference. Should any such risk factor affect the Company in an unexpected manner, or should assumptions underlying the forward-looking information prove incorrect, the actual results or events may differ materially from the results or events predicted. Accordingly. readers are cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur.

The forward-looking statements included in this press release are made as of the date of this press release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities laws. All forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

Neither the Canadian Securities Exchange ("CSE") nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

For additional information, please contact:
Sofiya Kleshchuk
Client Relations
+1 917 210 0543
Invest@ryahgroup.com

Gregory Wagner
Chief Executive Officer
+1 917 210 0543
Info@ryah.com

PRESS INQUIRIES
Joshua Greenwald
KCSA Strategic Communications
+1 646 379 7971
jgreenwald@kcsa.com

SOURCE: RYAH Medtech Inc



View source version on accesswire.com:
https://www.accesswire.com/666746/RYAH-Group-Inc-To-Present-at-LD-Micro-Conference-on-October-12th

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.